MoFo Life Sciences blog
FDA has been working intensely, mostly behind the scenes both in the United States and abroad, to address a number of important public health issues, including product safety, monitoring supply chain disruptions, and supporting emergency efforts to diagnose and treat the disease. In addition, FDA is addressing safety concerns with its own workforce. In this three-part article, we explain FDA’s efforts in each of these three areas and highlight the impact on different sectors of the healthcare industry impacted by the coronavirus and also FDA’s focused efforts.
Read the full blog post.